First Script saw continued decreasing opioid trends across our retail and mail-order programs in 2019, even while overall prescription trends saw a slight upward shift in utilization per claim and cost per claim. Even with these changes, opioids remain the #1 therapeutic class by usage and cost, however, 2019 marked the largest reduction of the last 5 years in the percentage of opioid scripts with greater than or equal to 90 MED. View the video blog here.
More stories
Genex
White Paper
Are You Dazed and Confused When It Comes to Behavioral Health IMEs?
Independent medical exams (IMEs) are a valuable tool for challenging claims.
Mitchell
News Release
Mitchell Selected as the Preferred North American Technology Provider of Vale’s Paintless Dent Repair (PDR) Technician Certification Program
Designation now extends beyond the US to Canada through agreement with Dented Paintless Repairs SAN DIEGO, Calif.—
Workers' Comp
News Release
Changes to the ODG Drug Formulary Impact Opioid Class
Effective December 2, 2022, the Official Disability Guidelines (ODG) Drug Formulary updated the opioid drug class.
Workers' Comp
News Release
Changes to the ODG Drug Formulary Impact Opioid Class
Effective December 2, 2022, the Official Disability Guidelines (ODG) Drug Formulary updated the opioid drug class.
Mitchell
Article
Average Length of Rental for Repairable Vehicles: Q3 2022
The quarterly LOR summary is produced by Enterprise Rent-A-Car.
Mitchell
Article
Current Used Vehicle Market Conditions: Q3 2022
September/October 2022 Kontos Kommentary The following commentary is produced by Tom Kontos, Chief Economist, ADESA Auctions.